Free press releases distribution network?

Agency / Source: OSO BioPharmaceuticals Manufacturing, LLC

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



OSO BioPharmaceuticals to Sponsor Forum on Subcutaneous Biologic Drug Delivery Trends - The 2011 DCAT Week Biologics Forum will present regulatory and pharmaceutical industry leaders discussing current requirements, trends and best practices for subcutaneous biologic drug delivery systems
OSO BioPharmaceuticals to Sponsor Forum on Subcutaneous Biologic Drug Delivery Trends

 

PRZOOM - /newswire/ - Albuquerque, NM, United States, 2011/02/22 - The 2011 DCAT Week Biologics Forum will present regulatory and pharmaceutical industry leaders discussing current requirements, trends and best practices for subcutaneous biologic drug delivery systems.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

OSO BioPharmaceuticals Manufacturing, LLC, will sponsor the Biologics Forum taking place March 16 as part of DCAT Week.

OsoBio is a contract manufacturing organization focusing on biologic and pharmaceutical injectables. Headquartered in Albuquerque, N.M., OsoBio specializes in products that require complex handling, including highly potent compounds.

The 2011 DCAT Week Biologics Forum will present regulatory and pharmaceutical industry leaders discussing current requirements, trends and best practices for subcutaneous biologic drug delivery systems. Participants will learn about innovations in products, tools and practices, as well as practical applications with case studies.

“Methodologies for qualifying primary container and delivery devices remain somewhat vague, which is why discussing case studies and sharing best practices is useful within the pharmaceutical industry, ” said Stuart Rose, president and CEO of OsoBio. “OsoBio is pleased to sponsor an event that advances quality and safety knowledge in our industry, ultimately benefiting the patients we all seek to serve.”

DCAT Week – sponsored annually by the Drug, Chemical and Associated Technologies Association (DCAT) – is considered by many participating industry representatives to be one of the most important meetings of the year.

The Biologics Forum is scheduled to take place Wednesday, March 16, from 1:15 pm. to 4:30 pm. in the Empire Room at the Waldorf-Astoria Hotel in New York City. A networking reception will follow.

DCAT invites representatives from non-member companies with interests in biologics to attend this program and networking event for the DCAT member price of $99. For registration information, visit osobio.com/.

OsoBio surpasses quality-assurance expectations within our industry. Our employees are industry veterans who provide innovative solutions to our clients’ most difficult projects.

Contact: Milton Boyer, VP business development and sales, 706-694-2514

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: OSO BioPharmaceuticals Manufacturing, LLC

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


OSO BioPharmaceuticals to Sponsor Forum on Subcutaneous Biologic Drug Delivery Trends

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Karen Stinneford - Sinclair & Co. for OsoBio 
919-833-9102 kstinneford[.]sinclair-co.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any OSO BioPharmaceuticals Manufacturing, LLC securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From OSO BioPharmaceuticals Manufacturing, LLC / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  Triggr & Bloom

Visit  JobsWare.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today